VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DFAN14A

Additional proxy soliciting materials filed by non-management

Proxy Filings
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |